Roche Diabetes Care and Senseonics Announce Distribution Agreement for the Eversense® CGM System Introducing the First Implantable Long-term Glucose Sensor
![Biosensors | Free Full-Text | Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study Biosensors | Free Full-Text | Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study](https://www.mdpi.com/biosensors/biosensors-12-00106/article_deploy/html/images/biosensors-12-00106-g001-550.jpg)
Biosensors | Free Full-Text | Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study
![Senseonics, TypeZero and Roche Diabetes Care team-up to trial a long-term artificial pancreas system Senseonics, TypeZero and Roche Diabetes Care team-up to trial a long-term artificial pancreas system](https://mhealthspot.com/wp-content/uploads/eversense.jpg)
Senseonics, TypeZero and Roche Diabetes Care team-up to trial a long-term artificial pancreas system
Global Continuous Glucose Monitoring (CGM) Market Report to 2027 - Players Include Abbott Laboratories, F. Hoffmann-La Roche, Medtronic and Novo Nordisk
![Dexcom and Roche Announce Partnerships for Future-Generation Integrated Pump-CGM Systems, Selling Dexcom Seven Plus to Physicians for Short-Term Use With Their Patients Dexcom and Roche Announce Partnerships for Future-Generation Integrated Pump-CGM Systems, Selling Dexcom Seven Plus to Physicians for Short-Term Use With Their Patients](https://diatribe.org/cdn-cgi/image/width=400/sites/default/files/images/nnn%2038%203.png)